Author
Listed:
- Atsuhito Nakao
(Ludwig Institute for Cancer Research, Box 595, Biomedical Center)
- Mozhgan Afrakhte
(University Hospital)
- Anita Morn
(Ludwig Institute for Cancer Research, Box 595, Biomedical Center)
- Takuya Nakayama
(L215, Oregon Health Sciences University, School of Medicine)
- Jan L. Christian
(L215, Oregon Health Sciences University, School of Medicine)
- Rainer Heuchel
(Ludwig Institute for Cancer Research, Box 595, Biomedical Center)
- Susumu Itoh
(Ludwig Institute for Cancer Research, Box 595, Biomedical Center)
- Masahiro Kawabata
(The Cancer Institute, Tokyo, The Japanese Foundation for Cancer Research, and Research for the Future Program, Japan Society for the Promotion of Science)
- Nils-Erik Heldin
(University Hospital)
- Carl-Henrik Heldin
(Ludwig Institute for Cancer Research, Box 595, Biomedical Center)
- Peter ten Dijke
(Ludwig Institute for Cancer Research, Box 595, Biomedical Center)
Abstract
TGF-β signals from the membrane to the nucleus through serine/threonine kinase receptors and their downstream effectors, termed SMAD proteins1. The activated TGF-β receptor induces phosphorylation of two such proteins, Smad2 and Smad3 (refs 2, 3, 5, 6), which form hetero-oligomeric complex(es) with Smad4/DPC4 (refs 5, 6, 7, 8, 9, 10) that translocate to the nucleus2,4,5,7, where they then regulate transcriptional responses11,12. However, the mechanisms by which the intracellular signals of TGF-β are switched off are unclear. Here we report the identification of Smad7, which is related to Smad6 (ref. 13). Transfection of Smad7 blocks responses mediated by TGF-β in mammalian cells, and injection of Smad7 RNA into Xenopus embryos blocks activin/TGF-β signalling. Smad7 associates stably with the TGF-β receptor complex, but is not phosphorylated upon TGF-β stimulation. TGFβ-mediated phosphorylation of Smad2 and Smad3 is inhibited by Smad7, indicating that the antagonistic effect of Smad7 is exerted at this important regulatory step. TGF-β rapidly induces expression of Smad7 mRNA, suggesting that Smad7 may participate in a negative feedback loop to control TGF-β responses.
Suggested Citation
Atsuhito Nakao & Mozhgan Afrakhte & Anita Morn & Takuya Nakayama & Jan L. Christian & Rainer Heuchel & Susumu Itoh & Masahiro Kawabata & Nils-Erik Heldin & Carl-Henrik Heldin & Peter ten Dijke, 1997.
"Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling,"
Nature, Nature, vol. 389(6651), pages 631-635, October.
Handle:
RePEc:nat:nature:v:389:y:1997:i:6651:d:10.1038_39369
DOI: 10.1038/39369
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:389:y:1997:i:6651:d:10.1038_39369. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.